Progressive multifocal leukoencephalopathy, natalizumab, and multiple sclerosis.
Berger
Thomas
T
Deisenhammer
Florian
F
D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D003951:Diagnostic Errors; D006801:Humans; D016899:Interferon-beta / Q000009:adverse effects*; D007968:Leukoencephalopathy, Progressive Multifocal / Q000139:chemically induced* / Q000175:diagnosis; D009103:Multiple Sclerosis / Q000175:diagnosis*; D000069442:Natalizumab
D000276:Adjuvants, Immunologic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab; D016899:Interferon-beta